Truvestments Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Truvestments Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-108	Closed	-$16.6K	–	780
2022 Q4	$16.6K	Hold	108	–	–	0.01%	404
2022 Q3	$14K	Hold	108	–	–	0.01%	375
2022 Q2	$15K	Buy	+108	New	+$14.9K	0.01%	369
2022 Q1	–	Sell	-108	Closed	-$17K	–	301
2021 Q4	$17K	Hold	108	–	–	0.01%	357
2021 Q3	$18K	Hold	108	–	–	0.01%	331
2021 Q2	$19K	Hold	108	–	–	0.01%	325
2021 Q1	$17K	Hold	108	–	–	0.01%	387
2020 Q4	$18K	Buy	+108	New	+$17.5K	0.01%	372
2020 Q3	–	Sell	-108	Closed	-$18K	–	398
2020 Q2	$18K	Buy	+108	New	+$16.9K	0.02%	317
2020 Q1	–	Sell	-3,148	Closed	-$468K	–	524
2019 Q4	$468K	Buy	3,148 +155	+5%	+$21.3K	0.32%	89
2019 Q3	$370K	Sell	2,993 -75	-2%	-$9.98K	0.24%	97
2019 Q2	$432K	Buy	3,068 +665	+28%	+$91.8K	0.29%	82
2019 Q1	$362K	Buy	+2,403	New	+$346K	0.28%	80
2018 Q3	$623K	Buy	+3,929	New	+$595K	0.3%	89

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Truvestments Capital's FBT Position: Q1 2023 in Review

Truvestments Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2023, closing a stake of 108 shares — an estimated $16.6K sold.

Truvestments Capital first reported a position in FBT in Q3 2018 and held it in 14 quarters. The position peaked at $623K in Q3 2018. 245 funds tracked by Wall St. Rank hold FBT as of Q1 2023.

Truvestments Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2023 after selling out during the quarter.
Truvestments Capital sold 108 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2023, an estimated $16.6K.
Truvestments Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 14 quarters.
Truvestments Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $623K in Q3 2018.
245 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2023.

Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.